306 related articles for article (PubMed ID: 33035386)
1. Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus.
Nakajima M; Rauramaa T; Mäkinen PM; Hiltunen M; Herukka SK; Kokki M; Musialowicz T; Jyrkkänen HK; Danner N; Junkkari A; Koivisto AM; Jääskeläinen JE; Miyajima M; Ogino I; Furuta A; Akiba C; Kawamura K; Kamohara C; Sugano H; Tange Y; Karagiozov K; Leinonen V; Arai H
Eur J Neurol; 2021 Feb; 28(2):389-400. PubMed ID: 33035386
[TBL] [Abstract][Full Text] [Related]
2. PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus.
Nagata Y; Bundo M; Sugiura S; Kamita M; Ono M; Hattori K; Yoshida S; Goto YI; Urakami K; Niida S
Mol Med Rep; 2017 Sep; 16(3):3034-3040. PubMed ID: 28714010
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.
Kawamura K; Miyajima M; Nakajima M; Kanai M; Motoi Y; Nojiri S; Akiba C; Ogino I; Xu H; Kamohara C; Yamada S; Karagiozov K; Ikeuchi T; Kondo A; Arai H
J Alzheimers Dis; 2021; 83(1):179-190. PubMed ID: 34275898
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Diagnostics of Alzheimer's Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
Vanninen A; Lukkarinen H; Kokkola T; Koivisto AM; Kokki M; Musialowicz T; Hiltunen M; Zetterberg H; Leinonen V; Herukka SK; Rauramaa T
J Alzheimers Dis; 2023; 94(2):727-736. PubMed ID: 37334597
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
Manniche C; Hejl AM; Hasselbalch SG; Simonsen AH
J Alzheimers Dis; 2019; 68(1):267-279. PubMed ID: 30741681
[TBL] [Abstract][Full Text] [Related]
6. Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.
Jurjević I; Miyajima M; Ogino I; Akiba C; Nakajima M; Kondo A; Kikkawa M; Kanai M; Hattori N; Arai H
J Alzheimers Dis; 2017; 56(1):317-325. PubMed ID: 27911315
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
8. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
[TBL] [Abstract][Full Text] [Related]
9. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
12. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
Yang F; Yang L; Fang X; Deng Y; Mao R; Yan A; Wei W
J Alzheimers Dis; 2023; 93(4):1341-1354. PubMed ID: 37182875
[TBL] [Abstract][Full Text] [Related]
13. Delayed clearance of cerebrospinal fluid tracer from choroid plexus in idiopathic normal pressure hydrocephalus.
Eide PK; Valnes LM; Pripp AH; Mardal KA; Ringstad G
J Cereb Blood Flow Metab; 2020 Sep; 40(9):1849-1858. PubMed ID: 31495299
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
Kanemoto H; Mori E; Tanaka T; Suehiro T; Yoshiyama K; Suzuki Y; Kakeda K; Wada T; Hosomi K; Kishima H; Kazui H; Hashimoto M; Ikeda M
Int Psychogeriatr; 2023 Sep; 35(9):509-517. PubMed ID: 34399871
[TBL] [Abstract][Full Text] [Related]
15. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
Azuma S; Kazui H; Kanemoto H; Suzuki Y; Sato S; Suehiro T; Matsumoto T; Yoshiyama K; Kishima H; Shimosegawa E; Tanaka T; Ikeda M
Psychogeriatrics; 2019 Nov; 19(6):527-538. PubMed ID: 30916850
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
Kang K; Ko PW; Jin M; Suk K; Lee HW
J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
[TBL] [Abstract][Full Text] [Related]
17. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
[TBL] [Abstract][Full Text] [Related]
18. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
[TBL] [Abstract][Full Text] [Related]
19. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
Kuroda T; Honma M; Mori Y; Futamura A; Sugimoto A; Kasai H; Yano S; Hieda S; Kasuga K; Ikeuchi T; Ono K
J Alzheimers Dis; 2022; 85(2):851-862. PubMed ID: 34864676
[TBL] [Abstract][Full Text] [Related]
20. Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases.
Braun M; Boström G; Ingelsson M; Kilander L; Löwenmark M; Nyholm D; Burman J; Niemelä V; Freyhult E; Kultima K; Virhammar J
Fluids Barriers CNS; 2023 Oct; 20(1):72. PubMed ID: 37833765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
